Next-generation sequencing can be used to continually assess and monitor risks in patients with leukaemia, a new proof-of-principle study has shown. The new application for the technique is part of a revolution in cancer treatment that has come about as a result of the precipitous drop in the cost of sequencing. This method could become […]
Read More